AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OPKO Health Inc.

Report Publication Announcement Nov 11, 2020

6963_rns_2020-11-11_b3dda819-0207-41ec-9211-8bc294380edc.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

OPKO Health to Participate in Three Upcoming Investment Conferences

MIAMI (November 11, 2020) – OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in three upcoming virtual investor conferences.

  • H.C. Wainwright 6 th Annual Israel Virtual Conference, November 12, 2020. Management will participate in a fireside chat on Thursday, November 12 th at 9:00 a.m. ET and will be available for one-on-one meetings.
  • Jefferies 2020 Virtual London Healthcare Conference, November 17-19, 2020. Management will deliver a company presentation on Wednesday, November 18 th at 10:15 a.m. ET and will be available for one-on-one meetings. A live and archived webcast of the presentation will be available in the Investors section of OPKO's website here.
  • Piper Sandler 32nd Annual Virtual Healthcare Conference, December 1-3, 2020. Management will participate in a fireside chat and will be available for one-on-one meetings. A replay of the fireside chat will be available in the Investors section of OPKO's website here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industryleading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations Yvonne Briggs, 310-691-7100 [email protected] or Bruce Voss, 310-691-7100 [email protected]

#

Talk to a Data Expert

Have a question? We'll get back to you promptly.